Science Explorer Back to mapMap
Discussion
Company · Rockville · United States

BioReliance (United States)

bioreliance.com/usROR OpenAlex
World rank, all time
#23,549
of 34,923
Rank in United States
#4,893
of 7,310
Research works
218
▼ 9% vs 2018-21
Citations
3.5k
16.1 per fractional work
Top-10% rate
12.6%
all institutions 10.0%
vs its own fields
0.91×
1.00× is exactly expected
Open access
33%
world 40%
International
30%
world 18%
BioReliance (United States)

Which fields of science does BioReliance (United States) work in?

In 2022-now, 36% of research at BioReliance (United States) is in Physical Sciences, 26% in Health Sciences. Its largest fields are Medicine (24%), Engineering (16%), Biochemistry, Genetics and Molecular Biology (14%). It does 1.4× the world's share of Life Sciences.

Physical Sciences: 9 fractional works · 36.3% of its workEngineering: 4 fractional works · 16.3% of its workMechanical Engineering: 1 fractional works · 2.8% of its workOcean Engineering: 1 fractional works · 2.5% of its workSafety, Risk, Reliability and Quality: 1 fractional works · 2.5% of its workBiomedical Engineering: 1 fractional works · 2.3% of its workMechanics of Materials: 0 fractional works · 1.8% of its workCivil and Structural Engineering: 0 fractional works · 1.4% of its workBuilding and Construction: 0 fractional works · 1.2% of its workAutomotive Engineering: 0 fractional works · 0.7% of its workElectrical and Electronic Engineering: 0 fractional works · 0.7% of its workControl and Systems Engineering: 0 fractional works · 0.3% of its workComputer Science: 2 fractional works · 7.3% of its workInformation Systems: 1 fractional works · 5.2% of its workSoftware: 0 fractional works · 1.4% of its workArtificial Intelligence: 0 fractional works · 0.7% of its workEnvironmental Science: 1 fractional works · 5.4% of its workEnvironmental Engineering: 1 fractional works · 3.1% of its workWater Science and Technology: 0 fractional works · 1.5% of its workEcological Modeling: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workMaterials Science: 1 fractional works · 2.4% of its workMaterials Chemistry: 0 fractional works · 1.7% of its workPolymers and Plastics: 0 fractional works · 0.7% of its workEnergy: 0 fractional works · 2.1% of its workGeneral Energy: 0 fractional works · 2.1% of its workMathematics: 0 fractional works · 2.1% of its workStatistics and Probability: 0 fractional works · 1.4% of its workApplied Mathematics: 0 fractional works · 0.7% of its workEarth and Planetary Sciences: 0 fractional works · 0.6% of its workGeochemistry and Petrology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 0 fractional works · 0.2% of its workHealth Sciences: 6 fractional works · 25.9% of its workMedicine: 6 fractional works · 24.1% of its workOncology: 3 fractional works · 10.7% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 2.0% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.7% of its workInfectious Diseases: 0 fractional works · 1.2% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.0% of its workSurgery: 0 fractional works · 0.9% of its workPharmacology: 0 fractional works · 0.8% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.7% of its workEpidemiology: 0 fractional works · 0.5% of its workGastroenterology: 0 fractional works · 0.5% of its workComplementary and alternative medicine: 0 fractional works · 0.5% of its workGeriatrics and Gerontology: 0 fractional works · 0.5% of its workNephrology: 0 fractional works · 0.5% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.5% of its workPathology and Forensic Medicine: 0 fractional works · 0.4% of its workAnatomy: 0 fractional works · 0.3% of its workBiochemistry: 0 fractional works · 0.3% of its workPhysiology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 1.7% of its workGeneral Health Professions: 0 fractional works · 0.7% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.3% of its workDentistry: 0 fractional works · 0.0% of its workLife Sciences: 6 fractional works · 23.9% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 14.1% of its workMolecular Biology: 2 fractional works · 9.9% of its workGenetics: 1 fractional works · 3.2% of its workCancer Research: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 1 fractional works · 3.4% of its workImmunology: 1 fractional works · 2.9% of its workMicrobiology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 2.7% of its workPlant Science: 0 fractional works · 1.7% of its workFood Science: 0 fractional works · 0.5% of its workAgronomy and Crop Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.3% of its workPharmacology: 1 fractional works · 2.3% of its workNeuroscience: 0 fractional works · 1.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.4% of its workSocial Sciences: 3 fractional works · 13.9% of its workSocial Sciences: 2 fractional works · 6.4% of its workSociology and Political Science: 1 fractional works · 3.2% of its workLaw: 0 fractional works · 1.0% of its workUrban Studies: 0 fractional works · 1.0% of its workPolitical Science and International Relations: 0 fractional works · 0.7% of its workCultural Studies: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDecision Sciences: 1 fractional works · 3.6% of its workInformation Systems and Management: 1 fractional works · 3.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 2.1% of its workClinical Psychology: 0 fractional works · 0.9% of its workDevelopmental and Educational Psychology: 0 fractional works · 0.7% of its workSocial Psychology: 0 fractional works · 0.5% of its workBusiness, Management and Accounting: 0 fractional works · 1.4% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 1.4% of its workArts and Humanities: 0 fractional works · 0.5% of its workArcheology: 0 fractional works · 0.5% of its workALL ITS WORKBioReliance(United States)24fractional works, 2022-now
Life Sciences24%Physical Sciences36%Health Sciences26%Social Sciences14%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 21 fields, with their numbers
    1. Engineering416.3%
    2. Computer Science27.3%
    3. Environmental Science15.4%
    4. Materials Science12.4%
    5. Energy02.1%
    6. Mathematics02.1%
    7. Earth and Planetary Sciences00.6%
    8. Chemistry00.2%
    1. Medicine624.1%
    2. Health Professions01.7%
    3. Dentistry00.0%
    1. Biochemistry, Genetics and Molecular Biology314.1%
    2. Immunology and Microbiology13.4%
    3. Agricultural and Biological Sciences12.7%
    4. Pharmacology, Toxicology and Pharmaceutics12.3%
    5. Neuroscience01.4%
    1. Social Sciences26.4%
    2. Decision Sciences13.6%
    3. Psychology02.1%
    4. Business, Management and Accounting01.4%
    5. Arts and Humanities00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.58× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.65× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 3.34× its world share, 1 worksImmunology and Micro…Neuroscience: 0.85× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.55× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.13× its world share, 0 worksChemistryComputer Science: 0.94× its world share, 2 worksComputer ScienceEarth and Planetary Sciences: 0.40× its world share, 0 worksEarth and Planetary …Energy: 2.26× its world share, 0 worksEnergyEngineering: 1.09× its world share, 4 worksEngineeringEnvironmental Science: 1.08× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.68× its world share, 1 worksMaterials ScienceMathematics: 1.77× its world share, 0 worksMathematicsDentistry: 0.06× its world share, 0 worksDentistryHealth Professions: 0.67× its world share, 0 worksHealth ProfessionsMedicine: 1.25× its world share, 6 worksMedicineArts and Humanities: 0.16× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.43× its world share, 0 worksBusiness, Management…Decision Sciences: 3.73× its world share, 1 worksDecision SciencesPsychology: 0.68× its world share, 0 worksPsychologySocial Sciences: 0.50× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.5×. Every wedge is a field page.

All 21 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics6.55×1 works
  2. Decision Sciences3.73×1 works
  3. Immunology and Microbiology3.34×1 works
  4. Biochemistry, Genetics and Molecular Biology2.65×3 works
  5. Energy2.26×0 works
  6. Mathematics1.77×0 works
  7. Medicine1.25×6 works
  8. Engineering1.09×4 works
  9. Environmental Science1.08×1 works
  10. Computer Science0.94×2 works
  11. Neuroscience0.85×0 works
  12. Materials Science0.68×1 works
  13. Psychology0.68×0 works
  14. Health Professions0.67×0 works
  15. Agricultural and Biological Sciences0.58×1 works
  16. Social Sciences0.50×2 works
  17. Business, Management and Accounting0.43×0 works
  18. Earth and Planetary Sciences0.40×0 works
  19. Arts and Humanities0.16×0 works
  20. Chemistry0.13×0 works
  21. Dentistry0.06×0 works

Who are the top researchers at BioReliance (United States)?

Ranked on the quality score, Ramadevi Gudi, Richard H.C. San and Reem H. Elbekai lead among researchers whose main affiliation is BioReliance (United States).

  1. 1 Ramadevi Gudi United States · #793,782 worldwide 1.8k citations · 55 works
  2. 2 Richard H.C. San United States · #1,279,590 worldwide 2.9k citations · 76 works
  3. 3 Reem H. Elbekai United States · #2,997,852 worldwide 1.1k citations · 39 works
  4. 4 Rohan M. Kulkarni United States · #3,336,235 worldwide 1k citations · 53 works
  5. 5 Melissa D. Denton United States · #3,563,139 worldwide 155 citations · 20 works
  6. 6 Audrey Chang United States · #3,570,652 worldwide 346 citations · 21 works
  7. 7 J. Deraisme United States · #3,953,967 worldwide 223 citations · 25 works
  8. 8 Nicolas Jeannée United States · #4,503,078 worldwide 342 citations · 42 works
  9. 9 Valentine O. Wagner United States · #4,619,299 worldwide 259 citations · 18 works
  10. 10 Matthieu Bourges United States · #4,929,665 worldwide 50 citations · 18 works
All ranked researchers at BioReliance (United States)

What are the most cited papers from BioReliance (United States)?

The most cited paper from BioReliance (United States) is "Nonseparable, Stationary Covariance Functions for Space–Time Data" (Tilmann Gneiting, 2002), with 791 citations. Next come "Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial" (592) and "Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial" (516).

Most cited papers
#PaperReleasedCitations
1 Nonseparable, Stationary Covariance Functions for Space–Time Data Tilmann Gneiting · Journal of the American Statistical Association Jun 2002 791
2 Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial Zixian Wang et al. · Cancer Cell Open access Mar 2022 592
3 Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial Ludwig Kappos et al. · Nature Medicine Oct 2000 516
4 Fourth International Workgroup on Genotoxicity testing: Results of the in vivo Comet assay workgroup Brian Burlinson, Raymond R. Tice, Günter Speit et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis 28 Nov 2006 511
5 Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial Hai-Qiang Mai et al. · Nature Medicine 2 Aug 2021 417
All 60 most cited papers, with filters and sorting

Which research topics does BioReliance (United States) publish most on?

By volume in 2022-now: Cancer Immunotherapy and Biomarkers, Soil Geostatistics and Mapping, Interdisciplinary Research and Collaboration and CAR-T cell therapy research.

Cancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksSoil Geostatistics and Mapping: 1 fractional worksInterdisciplinary Research and Collaboration: 0 fractional worksCAR-T cell therapy research: 0 fractional worksGlobal Energy Security and Policy: 0 fractional worksPharmacogenetics and Drug Metabolism: 0 fractional worksCRISPR and Genetic Engin…0CRISPR and Genetic Engineering: 0 fractional worksLung Cancer Research Studies: 0 fractional worksInformation and Cyber Security: 0 fractional worksIndustrial Engineering and Technologies: 0 fractional works
OncologyEnvironmental EngineeringInformation Systems and ManagementGeneral Energy4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 1 works
  2. 2 Soil Geostatistics and Mapping Environmental Engineering 1 works
  3. 3 Interdisciplinary Research and Collaboration Information Systems and Management 0 works
  4. 4 CAR-T cell therapy research Oncology 0 works
  5. 5 Global Energy Security and Policy General Energy 0 works
  6. 6 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
  7. 7 CRISPR and Genetic Engineering Molecular Biology 0 works
  8. 8 Lung Cancer Research Studies Oncology 0 works
  9. 9 Information and Cyber Security Information Systems 0 works
  10. 10 Industrial Engineering and Technologies Mechanical Engineering 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.9%not open67.1%

World: 40% of research is openly available.

with international co-authors29.5%domestic only70.5%

World: 18% is written across borders.

How has BioReliance (United States)'s research output changed?

Output in 2022-2025 was 9% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is BioReliance (United States) as a percentage of every work published that year, 0.00012% in 2024.

still counting0.00020%0.00040%0.00060%BioReliance (United States)0.000077% in 202519801990200020102020

Fractional works of BioReliance (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Rockville

All research institutions in Rockville

Share BioReliance (United States)'s ranking

BioReliance (United States) on Science Explorer

A card with BioReliance (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about BioReliance (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.